Here, we are going to share Orchid Pharma Share Price Target 2025, 2026, 2027, 2028, 2030, 2035, 2040 on the basis of its fundamental and technical analysis.
Orchid Pharma Limited, founded in 1992, is an Indian pharmaceutical company that specializes in the production and export of active pharmaceutical ingredients (APIs) and completed dosage forms.
The company works in more than 40 countries and offers a wide range of medicinal items.
Orchid Pharma Share Key Information
| Company Name | Orchid Pharma Ltd |
| Headquarters | |
| Sectors | Pharmaceuticals $ Drugs |
| Market Cap | ₹ 7,202.11 Cr. |
| No. of Shares | 5.07 Cr. |
| Book Value | ₹250.68 |
| Dividend Yield | 0% |
| ROCE | 8.96% |
| ROE | 9.72% |
| Face Value | ₹10 |
| Sales Growth | 23.05% |
| Profit Growth | 71.50% |
Orchid Pharma Business Sector
Active Pharmaceutical Ingredients (APIs): The company produces a variety of APIs, including cephalosporins, carbapenems, and penicillin derivatives.
Finished Dosage Forms: Orchid Pharma manufactures oral and injectable formulations across multiple therapeutic areas.
Research and Development: The company invests in R&D to develop new products and improve existing processes, ensuring compliance with international quality standards.
Board Members
- Mr. Ram Gopal Agarwal: Chairman and Non-Executive Director
- Mr. Manish Dhanuka: Managing Director
- Mr. Arjun Dhanuka: Non-Executive and Non-Independent Director
- Mr. Mridul Dhanuka: Whole-Time Director
Orchid Pharma Share Quarterly Results
| PARTICULARS | Jun 2024 (Cr.) | Sep 2024 (Cr.) |
|---|---|---|
| Net Sales | 244.41 | 222.70 |
| Total Expenditure | 211.16 | 193.11 |
| Operating Profit | 33.25 | 29.59 |
| Other Income | 7.77 | 7.96 |
| Interest | 3.47 | 3.30 |
| Depreciation | 8.44 | 8.63 |
| Exceptional Items | 0 | 0 |
| Profit Before Tax | 29.10 | 25.63 |
| Tax | 0 | 0 |
| Profit After Tax | 29.10 | 25.63 |
| Adjusted EPS (Rs) | 5.74 | 5.05 |
Orchid Pharma Company Profits and Losses
| PARTICULARS | Mar 2023 (Cr.) | Mar 2024 (Cr.) |
|---|---|---|
| Net Sales | 665.90 | 819.37 |
| Total Expenditure | 581.60 | 708.57 |
| Operating Profit | 84.29 | 110.80 |
| Other Income | 19.43 | 30.65 |
| Interest | 32.90 | 16.71 |
| Depreciation | 54.79 | 33.22 |
| Exceptional Items | 39.21 | 0 |
| Profit Before Tax | 55.25 | 91.52 |
| Tax | 0 | -3.23 |
| Net Profit | 54.19 | 94.75 |
| Adjusted EPS (Rs.) | 13.54 | 18.68 |
Orchid Pharma Share Price Target 2025-2040
| Year | Initial Target | Year-End Target |
|---|---|---|
| 2025 | ₹1470 | ₹1609 |
| 2026 | ₹1624 | ₹1720 |
| 2027 | ₹1737 | ₹1828 |
| 2028 | ₹1847 | ₹1941 |
| 2029 | ₹1955 | ₹2131 |
| 2030 | ₹2145 | ₹2320 |
| 2035 | ₹3250 | ₹3570 |
| 2040 | ₹4850 | ₹5450 |
Orchid Pharma Share Price Target 2025
| Year/Month | Predicted Target |
|---|---|
| January 2025 | ₹1470 |
| February 2025 | ₹1498 |
| March 2025 | ₹1515 |
| April 2025 | ₹1538 |
| May 2025 | ₹1598 |
| June 2025 | ₹1653 |
| July 2025 | ₹1635 |
| August 2025 | ₹1626 |
| September 2025 | ₹1605 |
| October 2025 | ₹1629 |
| November 2025 | ₹1633 |
| December 2025 | ₹1609 |
Based on the 2025 forecast, the initial target of Orchid Pharma share can could be ₹1470 and by the end of the year, the share price target is estimated to reach ₹1609.
Orchid Pharma Share Price Target 2026
| Year/Month | Predicted Target |
|---|---|
| January 2026 | ₹1624 |
| February 2026 | ₹1645 |
| March 2026 | ₹1706 |
| April 2026 | ₹1763 |
| May 2026 | ₹1745 |
| June 2026 | ₹1739 |
| July 2026 | ₹1714 |
| August 2026 | ₹1739 |
| September 2026 | ₹1743 |
| October 2026 | ₹1765 |
| November 2026 | ₹1699 |
| December 2026 | ₹1720 |
Based on the 2026 forecast, the initial target of Orchid Pharma share can could be ₹1624 and by the end of the year, the share price target is estimated to reach ₹1720.
Orchid Pharma Share Price Target 2027
| Year/Month | Predicted Target |
|---|---|
| January 2027 | ₹1737 |
| February 2027 | ₹1752 |
| March 2027 | ₹1814 |
| April 2027 | ₹1874 |
| May 2027 | ₹1855 |
| June 2027 | ₹1846 |
| July 2027 | ₹1824 |
| August 2027 | ₹1849 |
| September 2027 | ₹1851 |
| October 2027 | ₹1880 |
| November 2027 | ₹1809 |
| December 2027 | ₹1828 |
Based on the 2027 forecast, the initial target of Orchid Pharma share can could be ₹1737 and by the end of the year, the share price target is estimated to reach ₹1828.
Orchid Pharma Share Price Target 2028
| Year/Month | Predicted Target |
|---|---|
| January 2028 | ₹1847 |
| February 2028 | ₹1863 |
| March 2028 | ₹1924 |
| April 2028 | ₹1985 |
| May 2028 | ₹1965 |
| June 2028 | ₹1957 |
| July 2028 | ₹1933 |
| August 2028 | ₹1959 |
| September 2028 | ₹1966 |
| October 2028 | ₹1979 |
| November 2028 | ₹1919 |
| December 2028 | ₹1941 |
Based on the 2028 forecast, the initial target of Orchid Pharma share can could be ₹1847 and by the end of the year, the share price target is estimated to reach ₹1941.
Orchid Pharma Share Price Target 2029
| Year/Month | Predicted Target |
|---|---|
| January 2029 | ₹1955 |
| February 2029 | ₹1972 |
| March 2029 | ₹2034 |
| April 2029 | ₹2093 |
| May 2029 | ₹2074 |
| June 2029 | ₹2070 |
| July 2029 | ₹2043 |
| August 2029 | ₹2068 |
| September 2029 | ₹2085 |
| October 2029 | ₹2110 |
| November 2029 | ₹2142 |
| December 2029 | ₹2131 |
Based on the 2029 forecast, the initial target of Orchid Pharma share can could be ₹1955 and by the end of the year, the share price target is estimated to reach ₹2131.
Orchid Pharma Share Price Target 2030
| Year/Month | Predicted Target |
|---|---|
| January 2030 | ₹2145 |
| February 2030 | ₹2154 |
| March 2030 | ₹2198 |
| April 2030 | ₹2175 |
| May 2030 | ₹2189 |
| June 2030 | ₹2210 |
| July 2030 | ₹2253 |
| August 2030 | ₹2242 |
| September 2030 | ₹2262 |
| October 2030 | ₹2275 |
| November 2030 | ₹2295 |
| December 2030 | ₹2320 |
Based on the 2030 forecast, the initial target of Orchid Pharma share can could be ₹2145 and by the end of the year, the share price target is estimated to reach ₹2320.
Orchid Pharma Share Price Target 2035
| Year/Month | Predicted Target |
|---|---|
| January 2035 | ₹3250 |
| April 2035 | ₹3310 |
| July 2035 | ₹3395 |
| October 2035 | ₹3490 |
| December 2035 | ₹3570 |
Based on the 2035 forecast, the initial target of Orchid Pharma share can could be ₹3250 and by the end of the year, the share price target is estimated to reach ₹3570.
Orchid Pharma Share Price Target 2040
| Year/Month | Predicted Target |
|---|---|
| January 2040 | ₹4850 |
| April 2040 | ₹4990 |
| July 2040 | ₹5140 |
| October 2040 | ₹5280 |
| December 2040 | ₹5450 |
Based on the 2040 forecast, the initial target of Orchid Pharma share can could be ₹4850 and by the end of the year, the share price target is estimated to reach ₹5450.
Orchid Pharma Shareholding Pattern
| Terms | Percentage |
|---|---|
| Promoters | 69.84% |
| FIIs | 1.94% |
| DIIs | 18.29% |
| Others | 0% |
| Public | 9.93% |
Orchid Pharma Company Competitors
- Shilpa Medicare
- Aarti Pharmalabs
- Supriya Lifescience
- AMI Organics
- Unichem Lab
Bull Case of Orchid Pharma (Reasons to Invest)
The Company, Orchid Pharma Ltd has shown a very good profit growth of 44.04% and revenue growth of 22.05% for the last 3 years.
The company have done great work by decreasing its debt by 197.09 Cr. in last financial year.
Operating in over 40 countries, the company has established a strong international footprint, enhancing revenue potential.
Bear Case of Orchid Pharma (Risks Involved)
The Orchid Pharma company has shown very poor ROE of 3.26% over the last 3 years.
Moreover, company is trading at PE of 60.80 which is considered as a high valued company.
Apart from these, the pharmaceutical industry is highly competitive, with numerous players vying for market share, potentially impacting profitability.
Orchid Pharma Share Price Target: FAQ
What will be the target of Orchid Pharma Share for the year 2025?
By the end of the year 2025, its share price can reach ₹1609.
What will be the target of Orchid Pharma Share for the year 2026?
By the end of the year 2026, its share price can reach ₹1720.
What will be the target of Orchid Pharma Share for the year 2027?
By the end of the year 2027, its share price can reach ₹1828.
What will be the target of Orchid Pharma Share for the year 2028?
By the end of the year 2028, its share price can reach ₹1941.
What will be the target of Orchid Pharma Share for the year 2029?
By the end of the year 2029, its share price can reach ₹2131.
What will be the target of Orchid Pharma Share for the year 2030?
By the end of the year 2030 its share price can reach ₹2320.
What is the Current market cap of Orchid Pharma company?
At present the market cap of this company is ₹ 7,202.11 Cr.
What is the NSE symbol of Orchid Pharma company?
The symbol of this company in NSE exchange is ORCHIDPHARMA.
What is the BSE symbol of Orchid Pharma company?
The symbol of this company in BSE exchange is 524372.
Read also:
Alok Industries Share Price Target 2025 to 2040, Detailed Analysis
AMI Organics Share Price Target 2025 to 2040, Detailed Analysis
Aarti Pharmalabs Share Price Target 2025 to 2040, Detailed Analysis
